{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:24:27Z","timestamp":1759134267092},"reference-count":49,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Camb Q Healthc Ethics"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p>The available treatments for disorders affecting large segments of the population are often costly, complex, and only marginally effective, and many have numerous side effects. These disorders include dementias, debilitating neurological disorders, the multiple types of drug addiction, and the spectrum of mental health disorders.<\/jats:p><jats:p>Preliminary studies have shown that a variety of psychedelic and similar U.S. Drug Enforcement Administration Schedule I drugs may offer better treatment options than those that currently exist and pose potentially the same or even less risk than do legal psychoactive (alcohol, caffeine, nicotine) and nonpsychoactive (aspirin, acetaminophen, ibuprofen) substances. The pharmaceutical industry and academia, however, have largely avoided this avenue of research.<\/jats:p><jats:p>Fairness to the affected populations demands that these drugs be adequately studied and, if they or their congeners are shown to be effective, made available with the proper caveats, instructions, and protections that other potentially abused medications (e.g., narcotics) receive. These substances may prove to relieve patients\u2019 struggles with less effective treatments and decrease mortality from nontreatment of some conditions.<\/jats:p>","DOI":"10.1017\/s0963180118000518","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T16:07:25Z","timestamp":1545322045000},"page":"168-177","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["\u201cGo Ask Alice\u201d: The Case for Researching Schedule I Drugs"],"prefix":"10.1017","volume":"28","author":[{"given":"KENNETH V.","family":"ISERSON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"S0963180118000518_ref45","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.557"},{"key":"S0963180118000518_ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1635-z"},{"key":"S0963180118000518_ref40","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195707000-00014"},{"key":"S0963180118000518_ref38","doi-asserted-by":"publisher","DOI":"10.1007\/BF01567467"},{"key":"S0963180118000518_ref37","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.108.8.579"},{"key":"S0963180118000518_ref36","first-page":"241","article-title":"25 as an aid in psychotherapy: Preliminary report of a new drug","volume":"11","author":"Busch","year":"1950","journal-title":"Diseases of the Nervous System"},{"key":"S0963180118000518_ref35","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1171-11.2011"},{"key":"S0963180118000518_ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565653"},{"key":"S0963180118000518_ref29","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000436"},{"key":"S0963180118000518_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"S0963180118000518_ref22","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000113"},{"key":"S0963180118000518_ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0542-y"},{"key":"S0963180118000518_ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"S0963180118000518_ref17","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.131.11.1247"},{"key":"S0963180118000518_ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107069029"},{"key":"S0963180118000518_ref12","doi-asserted-by":"publisher","DOI":"10.1037\/10546-022"},{"key":"S0963180118000518_ref10","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.84"},{"key":"S0963180118000518_ref8","year":"2018","journal-title":"Controlled Substance Schedules"},{"key":"S0963180118000518_ref7","year":"2018","journal-title":"Understanding Unapproved Use of Approved Drugs \u201cOff Label\u201d"},{"key":"S0963180118000518_ref6","year":"2018","journal-title":"Burden of Tobacco Use in the U.S."},{"key":"S0963180118000518_ref4","year":"2018","journal-title":"Statistics"},{"key":"S0963180118000518_ref9","first-page":"221","volume-title":"Psychedelic Drugs Reconsidered","author":"Grinspoon","year":"1979"},{"key":"S0963180118000518_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"S0963180118000518_ref47","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1985.10524328"},{"key":"S0963180118000518_ref14","volume-title":"Everything You Wanted to Know About Microdosing (But Were Afraid to Ask)","author":"Gregoire","year":"2017"},{"key":"S0963180118000518_ref46","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1966.19.1.211"},{"key":"S0963180118000518_ref26","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114552713"},{"key":"S0963180118000518_ref23","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.5.934"},{"key":"S0963180118000518_ref48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.20.2701"},{"key":"S0963180118000518_ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195402000-00001"},{"key":"S0963180118000518_ref32","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1110"},{"key":"S0963180118000518_ref2","year":"2018","journal-title":"Statistics"},{"key":"S0963180118000518_ref1","volume-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"S0963180118000518_ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"S0963180118000518_ref3","year":"2018","journal-title":"Alcohol Facts and Statistics"},{"key":"S0963180118000518_ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410363490"},{"key":"S0963180118000518_ref49","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.776"},{"key":"S0963180118000518_ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"S0963180118000518_ref44","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2016.1170135"},{"key":"S0963180118000518_ref33","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1320802"},{"key":"S0963180118000518_ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112439253"},{"key":"S0963180118000518_ref5","year":"2018","journal-title":"Opioid Overdose Crisis"},{"key":"S0963180118000518_ref24","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000219761.05466.43"},{"key":"S0963180118000518_ref28","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2014-1496"},{"key":"S0963180118000518_ref43","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"S0963180118000518_ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112456611"},{"key":"S0963180118000518_ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"S0963180118000518_ref34","first-page":"1","article-title":"Changes in withdrawal and craving scores in participants undergoing opioid detoxification utilizing ibogaine","author":"Malcolm","year":"2018","journal-title":"Journal of Psychoactive Drugs"},{"key":"S0963180118000518_ref11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.15288\/qjsa.1959.20.577","article-title":"Use of d-lysergic acid diethylamide in the treatment of alcoholism","volume":"20","author":"Chwelos","year":"1959","journal-title":"Quarterly Journal of Studies on Alcohol"}],"container-title":["Cambridge Quarterly of Healthcare Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0963180118000518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T19:22:26Z","timestamp":1605727346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0963180118000518\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0963180118000518"],"URL":"https:\/\/doi.org\/10.1017\/s0963180118000518","relation":{},"ISSN":["0963-1801","1469-2147"],"issn-type":[{"value":"0963-1801","type":"print"},{"value":"1469-2147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}